Exact Mass: 479.1919
Exact Mass Matches: 479.1919
Found 500 metabolites which its exact mass value is equals to given mass value 479.1919
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Nicardipine
A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents. [PubChem] CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3807; ORIGINAL_PRECURSOR_SCAN_NO 3803 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3813; ORIGINAL_PRECURSOR_SCAN_NO 3810 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7839; ORIGINAL_PRECURSOR_SCAN_NO 7837 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7818; ORIGINAL_PRECURSOR_SCAN_NO 7816 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7789; ORIGINAL_PRECURSOR_SCAN_NO 7787 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3822; ORIGINAL_PRECURSOR_SCAN_NO 3819 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3813; ORIGINAL_PRECURSOR_SCAN_NO 3811 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3884; ORIGINAL_PRECURSOR_SCAN_NO 3883 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3807; ORIGINAL_PRECURSOR_SCAN_NO 3805 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7827; ORIGINAL_PRECURSOR_SCAN_NO 7825 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7806; ORIGINAL_PRECURSOR_SCAN_NO 7805 CONFIDENCE standard compound; INTERNAL_ID 442; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7845; ORIGINAL_PRECURSOR_SCAN_NO 7843 C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
JNJ-38431055
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate
4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-[7-methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]-2(1H)-pyridinone
3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester
beta-D-fructofuranosyl-(2->1)-alpha-D-[2-O-L-hystidyl]glucopyranoside
nicardipine
C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Ala Cys Met Arg
Ala Cys Arg Met
Ala Cys Thr Trp
Ala Cys Trp Thr
Ala Asp Phe Gln
Ala Asp Gln Phe
Ala Glu Phe Asn
Ala Glu Asn Phe
Ala Phe Asp Gln
Ala Phe Glu Asn
Ala Phe Asn Glu
Ala Phe Gln Asp
Ala Met Cys Arg
Ala Met Met Gln
Ala Met Gln Met
Ala Met Arg Cys
Ala Asn Glu Phe
Ala Asn Phe Glu
Ala Gln Asp Phe
Ala Gln Phe Asp
Ala Gln Met Met
Ala Arg Cys Met
Ala Arg Met Cys
Ala Thr Cys Trp
Ala Thr Trp Cys
Ala Trp Cys Thr
Ala Trp Thr Cys
Cys Ala Met Arg
Cys Ala Arg Met
Cys Ala Thr Trp
Cys Ala Trp Thr
Cys Cys Arg Val
Cys Cys Val Arg
Cys Asp Arg Ser
Cys Asp Ser Arg
Cys Glu Lys Thr
Cys Glu Thr Lys
Cys Phe Asn Pro
Cys Phe Pro Asn
Cys Ile Met Asn
Cys Ile Asn Met
Cys Lys Glu Thr
Cys Lys Thr Glu
Cys Leu Met Asn
Cys Leu Asn Met
Cys Met Ala Arg
Cys Met Ile Asn
Cys Met Leu Asn
Cys Met Asn Ile
Cys Met Asn Leu
Cys Met Gln Val
Cys Met Arg Ala
Cys Met Val Gln
Cys Asn Phe Pro
Cys Asn Ile Met
Cys Asn Leu Met
Cys Asn Met Ile
Cys Asn Met Leu
Cys Asn Pro Phe
Cys Pro Phe Asn
Cys Pro Asn Phe
Cys Gln Met Val
Cys Gln Val Met
Cys Arg Ala Met
Cys Arg Cys Val
Cys Arg Asp Ser
Cys Arg Met Ala
Cys Arg Ser Asp
Cys Arg Val Cys
Cys Ser Asp Arg
Cys Ser Arg Asp
Cys Thr Ala Trp
Cys Thr Glu Lys
Cys Thr Lys Glu
Cys Thr Trp Ala
Cys Val Cys Arg
Cys Val Met Gln
Cys Val Gln Met
Cys Val Arg Cys
Cys Trp Ala Thr
Cys Trp Thr Ala
Asp Ala Phe Gln
Asp Ala Gln Phe
Asp Cys Arg Ser
Asp Cys Ser Arg
Asp Phe Ala Gln
Asp Phe Gln Ala
Asp Lys Met Ser
Asp Lys Ser Met
Asp Met Lys Ser
Asp Met Ser Lys
Asp Gln Ala Phe
Asp Gln Phe Ala
Asp Arg Cys Ser
Asp Arg Ser Cys
Asp Ser Cys Arg
Asp Ser Lys Met
Asp Ser Met Lys
Asp Ser Arg Cys
Glu Ala Phe Asn
Glu Ala Asn Phe
Glu Cys Lys Thr
Glu Cys Thr Lys
Glu Phe Ala Asn
Glu Phe Gly Gln
Glu Phe Asn Ala
Glu Phe Gln Gly
Glu Gly Phe Gln
Glu Gly Gln Phe
Glu Lys Cys Thr
Glu Lys Thr Cys
Glu Asn Ala Phe
Glu Asn Phe Ala
Glu Gln Phe Gly
Glu Gln Gly Phe
Glu Gln Thr Cys
Glu Ser Met Asn
Glu Ser Asn Met
Glu Thr Cys Lys
Glu Thr Cys Gln
Glu Thr Lys Cys
Glu Thr Gln Cys
Phe Ala Asp Gln
Phe Ala Glu Asn
Phe Ala Asn Glu
Phe Ala Gln Asp
Phe Cys Asn Pro
Phe Cys Pro Asn
Phe Asp Ala Gln
Phe Asp Gln Ala
Phe Glu Ala Asn
Phe Glu Gly Gln
Phe Glu Asn Ala
Phe Glu Gln Gly
Phe Gly Glu Gln
Phe Gly Gln Glu
Phe Asn Ala Glu
Phe Asn Cys Pro
Phe Asn Glu Ala
Phe Asn Pro Cys
Phe Pro Cys Asn
Phe Pro Asn Cys
Phe Gln Ala Asp
Phe Gln Asp Ala
Phe Gln Glu Gly
Phe Gln Gly Glu
Gly Glu Phe Gln
Gly Glu Gln Phe
Gly Phe Glu Gln
Gly Phe Gln Glu
Gly Met Ser Trp
Gly Met Trp Ser
Gly Gln Glu Phe
Gly Gln Phe Glu
Gly Ser Met Trp
Gly Ser Trp Met
Gly Trp Met Ser
Gly Trp Ser Met
Ile Cys Met Asn
Ile Cys Asn Met
Ile Met Cys Asn
Ile Met Asn Cys
Ile Asn Cys Met
Ile Asn Met Cys
Lys Cys Asp Asp
Lys Cys Glu Thr
Lys Cys Thr Glu
Lys Asp Cys Asp
Lys Asp Asp Cys
Lys Asp Met Ser
Lys Asp Ser Met
Lys Glu Cys Thr
Lys Glu Thr Cys
Lys Met Asp Ser
Lys Met Ser Asp
Lys Ser Asp Met
Lys Ser Met Asp
Lys Thr Cys Glu
Lys Thr Glu Cys
Leu Cys Met Asn
Leu Cys Asn Met
Leu Met Cys Asn
Leu Met Asn Cys
Leu Asn Cys Met
Leu Asn Met Cys
Met Ala Cys Arg
Met Ala Met Gln
Met Ala Gln Met
Met Ala Arg Cys
Met Cys Ala Arg
Met Cys Ile Asn
Met Cys Leu Asn
Met Cys Asn Ile
Met Cys Asn Leu
Met Cys Gln Val
Met Cys Arg Ala
Met Cys Val Gln
Met Asp Lys Ser
Met Asp Asn Thr
Met Asp Gln Ser
Met Asp Ser Lys
Met Asp Ser Gln
Met Asp Thr Asn
Met Glu Asn Ser
Met Glu Ser Asn
Met Gly Ser Trp
Met Gly Trp Ser
Met Ile Cys Asn
Met Ile Asn Cys
Met Lys Asp Ser
Met Lys Ser Asp
Met Leu Cys Asn
Met Leu Asn Cys
Met Met Ala Gln
Met Met Gln Ala
Met Asn Cys Ile
Met Asn Cys Leu
Met Asn Asp Thr
Met Asn Glu Ser
Met Asn Ile Cys
Met Asn Leu Cys
Met Asn Ser Glu
Met Asn Thr Asp
Met Gln Ala Met
Met Gln Cys Val
Met Gln Asp Ser
Met Gln Met Ala
Met Gln Ser Asp
Met Gln Thr Thr
Met Gln Val Cys
Met Arg Ala Cys
Met Arg Cys Ala
Met Ser Asp Lys
Met Ser Asp Gln
Met Ser Glu Asn
Met Ser Gly Trp
Met Ser Lys Asp
Met Ser Asn Glu
Met Ser Trp Gly
Met Thr Gln Thr
Met Thr Thr Gln
Met Val Cys Gln
Met Val Gln Cys
Met Trp Gly Ser
Met Trp Ser Gly
Asn Ala Glu Phe
Asn Ala Phe Glu
Asn Cys Phe Pro
Asn Cys Ile Met
Asn Cys Leu Met
Asn Cys Met Ile
Asn Cys Met Leu
Asn Cys Pro Phe
Asn Glu Ala Phe
Asn Glu Phe Ala
Asn Phe Ala Glu
Asn Phe Cys Pro
Asn Phe Glu Ala
Asn Phe Pro Cys
Asn Ile Cys Met
Asn Ile Met Cys
Asn Leu Cys Met
Asn Leu Met Cys
Asn Met Cys Ile
Asn Met Cys Leu
Asn Met Ile Cys
Asn Met Leu Cys
Asn Pro Cys Phe
Asn Pro Phe Cys
Asn Pro Ser Tyr
Asn Pro Tyr Ser
Asn Ser Pro Tyr
Asn Ser Tyr Pro
Asn Tyr Pro Ser
Asn Tyr Ser Pro
Pro Cys Phe Asn
Pro Cys Asn Phe
Pro Phe Cys Asn
Pro Phe Asn Cys
Pro Asn Cys Phe
Pro Asn Phe Cys
Pro Asn Ser Tyr
Pro Asn Tyr Ser
Pro Ser Asn Tyr
Pro Ser Tyr Asn
Pro Tyr Asn Ser
Pro Tyr Ser Asn
Gln Ala Asp Phe
Gln Ala Phe Asp
Gln Ala Met Met
Gln Cys Met Val
Gln Cys Val Met
Gln Asp Ala Phe
Gln Asp Phe Ala
Gln Glu Phe Gly
Gln Glu Gly Phe
Gln Phe Ala Asp
Gln Phe Asp Ala
Gln Phe Glu Gly
Gln Phe Gly Glu
Gln Gly Glu Phe
Gln Gly Phe Glu
Gln Met Ala Met
Gln Met Cys Val
Gln Met Met Ala
Gln Met Thr Thr
Gln Met Val Cys
Gln Thr Met Thr
Gln Thr Thr Met
Gln Val Cys Met
Gln Val Met Cys
Arg Ala Cys Met
Arg Ala Met Cys
Arg Cys Ala Met
Arg Cys Cys Val
Arg Cys Asp Ser
Arg Cys Met Ala
Arg Cys Ser Asp
Arg Cys Val Cys
Arg Asp Cys Ser
Arg Asp Ser Cys
Arg Met Ala Cys
Arg Met Cys Ala
Arg Ser Cys Asp
Arg Ser Asp Cys
Arg Val Cys Cys
Ser Cys Asp Arg
Ser Cys Arg Asp
Ser Asp Cys Arg
Ser Asp Lys Met
Ser Asp Met Lys
Ser Asp Arg Cys
Ser Gly Met Trp
Ser Gly Trp Met
Ser Lys Asp Met
Ser Lys Met Asp
Ser Met Asp Lys
Ser Met Gly Trp
Ser Met Lys Asp
Ser Met Trp Gly
Ser Asn Pro Tyr
Ser Asn Tyr Pro
Ser Pro Asn Tyr
Ser Pro Tyr Asn
Ser Arg Cys Asp
Ser Arg Asp Cys
Ser Ser Thr Trp
Ser Ser Trp Thr
Ser Thr Ser Trp
Ser Thr Trp Ser
Ser Trp Gly Met
Ser Trp Met Gly
Ser Trp Ser Thr
Ser Trp Thr Ser
Ser Tyr Asn Pro
Ser Tyr Pro Asn
Thr Ala Cys Trp
Thr Ala Trp Cys
Thr Cys Ala Trp
Thr Cys Glu Lys
Thr Cys Lys Glu
Thr Cys Trp Ala
Thr Glu Cys Lys
Thr Glu Lys Cys
Thr Lys Cys Glu
Thr Lys Glu Cys
Thr Met Gln Thr
Thr Met Thr Gln
Thr Gln Met Thr
Thr Gln Thr Met
Thr Ser Ser Trp
Thr Ser Trp Ser
Thr Thr Met Gln
Thr Thr Gln Met
Thr Trp Ala Cys
Thr Trp Cys Ala
Thr Trp Ser Ser
Val Cys Cys Arg
Val Cys Met Gln
Val Cys Gln Met
Val Cys Arg Cys
Val Met Cys Gln
Val Met Gln Cys
Val Gln Cys Met
Val Gln Met Cys
Val Arg Cys Cys
Trp Ala Cys Thr
Trp Ala Thr Cys
Trp Cys Ala Thr
Trp Cys Thr Ala
Trp Gly Met Ser
Trp Gly Ser Met
Trp Met Gly Ser
Trp Met Ser Gly
Trp Ser Gly Met
Trp Ser Met Gly
Trp Ser Ser Thr
Trp Ser Thr Ser
Trp Thr Ala Cys
Trp Thr Cys Ala
Trp Thr Ser Ser
Tyr Asn Pro Ser
Tyr Asn Ser Pro
Tyr Pro Asn Ser
Tyr Pro Ser Asn
Tyr Ser Asn Pro
Tyr Ser Pro Asn
[N-[alpha-[2-(Dibutylglycinamido)phenyl]benzylidene]glycinato]nickel
4-ethynyl-3-[3-fluoro-4-[(2-methylimidazo[4,5-c]pyridin-1-yl)methyl]benzoyl]-N,N-dimethylindole-1-carboxamide
(S)-trans-N-3-{3-(2-aminocyclopropyl)phenoxy}-1-benzylcarbamoyl propylbenzamide hydrochloride
(2S)-2-[[4-[(2-amino-4-oxo-7,8-dihydro-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,dihydrate
3-(2-(BENZYLOXY)-5-BROMOPHENYL)-N,N-DIISOPROPYL-3-PHENYLPROPAN-1-AMINE
BMS-536924
PROPIONIC ACID (1R,2S)-2-[N-BENZYL-N-(MESITYLENESULFONYL)AMINO]-1-PHENYLPROPYL ESTER
2,5-dibutoxy-4-(morpholino)benzenediazonium hexafluorophosphate
(1S,2R)-2-[N-Benzyl-N-(mesitylenesulfonyl)amino]-1-phenylpropyl Propionate
N-(3-Cyclopropyl(5,6,7,8,9,10-hexahydro-2-oxo-2H-cycloocta[B]pyran-3-YL)methyl)phenylbenzensulfonamide
3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester
2-Furanyl-[4-[2-(2-methoxyphenyl)-5-phenyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]methanone
(3R,3aS,7R,7aS)-3-[5-(1-benzothiophen-2-yl)-2-methoxyphenyl]-7-methyl-2-(phenylmethyl)-3a,6,7,7a-tetrahydro-3H-isoindol-1-one
3-Furanyl-[4-[2-(4-methoxyphenyl)-5-phenyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]methanone
4-methoxy-N-[[4-[oxo-[4-(phenylmethyl)-1-piperazinyl]methyl]phenyl]methyl]benzenesulfonamide
3-Furanyl-[4-[2-(3-methoxyphenyl)-5-phenyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]methanone
N-[2,5-diethoxy-4-[[(3-methoxyanilino)-sulfanylidenemethyl]amino]phenyl]-4-methylbenzamide
[4-[5-Tert-butyl-3-[(2-chlorophenyl)methyl]-7-triazolo[4,5-d]pyrimidinyl]-1-piperazinyl]-(2-furanyl)methanone
1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-[(dimethylamino)methyl]-N-[(E)-[2-[(4-fluorophenyl)methoxy]phenyl]methylideneamino]triazole-4-carboxamide
2-fluoro-N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
2-fluoro-N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
2-[(2R,4aS,12aR)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
2-[(2S,4aS,12aS)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
(1R,9S,10S,11S)-12-ethyl-5-(2-fluorophenyl)-N-[(4-fluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
3-fluoro-N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-fluoro-N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-fluoro-N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-fluoro-N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
2-fluoro-N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
2-[(2R,4aR,12aS)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
(1S,9R,10R,11R)-12-ethyl-5-(2-fluorophenyl)-N-[(4-fluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
3-fluoro-N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-fluoro-N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-fluoro-N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
2-fluoro-N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
2-fluoro-N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
4-fluoro-N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
4-fluoro-N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
2-[(2S,4aS,12aR)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
2-[(2R,4aS,12aS)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
3-fluoro-N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
2-fluoro-N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
4-fluoro-N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
4-fluoro-N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
4-fluoro-N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
2-[(2R,4aR,12aR)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
2-[(2S,4aR,12aR)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
2-[(2S,4aR,12aS)-8-(methanesulfonamido)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-cyclohexylacetamide
3-O-[2-[benzyl(methyl)amino]ethyl] 5-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylate
3-[2-benzylsulanyl-1,2-bis(4-methoxyphenyl)ethyl]-1H-indole
1-Ethyl-4-(5-methylfuran-2-carbonyl)-1-(3-morpholin-4-ylpropyl)spiro[indole-3,5-pyrrolidine]-2,2,3-trione
2,6-dimethyl-4-(3-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylic acid O3-methyl ester O5-[2-[methyl-(phenylmethyl)amino]ethyl] ester
ARC 239 (dihydrochloride)
ARC 239 dihydrochloride is a selective α2B/2C adrenoceptor antagonist (pKd values are 5.95, 7.41 and 7.56 at α2A, α2B, and α2C receptors respectively). ARC 239 dihydrochloride binds to CHO cell membranes expressing human recombinant a2A-, a2B- or a2C-adrenoceptor subtypes with pKis of 5.6, 8.4, and 7.08, respectively[1].